Catecholaminergic Gene Variants: Contribution in ADHD and Associated Comorbid Attributes in the Eastern Indian Probands

Table 5

Analysis of allelic transmission in ADHD probands with different co-morbidities.

Site	ADHD comorbidity		ADHD + CD		ADHD + LD		ADHD + ODD		ADHD + MD
	𝜒^2 (P)	OR; (95% CI)	𝜒^2 (P)	OR; (95% CI)	𝜒^2 (P)	OR; (95% CI)	𝜒^2 (P)	OR; (95% CI)	𝜒^2 (P)	OR; (95% CI)
rs3837091	7.60; (0.006)	0.35; (0.25–0.50)	5.43; (0.01)	0.61; (0.45–0.82)	0.67; (0.41)	0.72; (0.54–0.96)	0.53; (0.47)	0.69; (0.52–0.93)	0.00; (1.00)	1.00; (0.76–1.32)
rs3735273	0.04; (0.84)	0.92; (0.06–14.83)	0.17; (0.68)	0.92; (0.70–1.22)	0.14; (0.70)	0.85; (0.64–1.12)	1.36; (0.24)	2.03; (1.49–2.77)	0.09; (0.76)	1.22; (0.92–1.62)
rs1799732	0.37; (0.55)	0.69; (0.20–2.29)	0.44; (0.51)	1.56; (0.42–5.87)	7.49; (0.006)	6.33; (1.35–29.68)	0.70; (0.40)	0.63; (0.21–1.90)	0.22; (0.64)	1.55; (0.24–9.85)
rs4646984	0.17; (0.68)	0.84; (0.38–1.89)	5.14; (0.02)	2.58; (1.12–5.93)	1.41; (0.24)	1.6; (0.73–3.5)	0.13; (0.72)	0.88; (0.43–1.78)	1.60; (0.20)	0.52; (0.19–1.44)
rs4646983	1.70; (0.19)	0.50; (0.17–1.44)	1.81; (0.17)	2.53; (0.62–10.63)	0.32; (0.57)	1.38; (0.45–4.21)	0.90; (0.34)	1.85; (0.51–6.67)	1.11; (0.29)	3.22; (0.32–32.89)
rs165599	1.64; (0.20)	1.60; (0.78–3.29)	1.64; (0.20)	0.58; (0.25–1.34)	0.03; (0.86)	1.07; (0.52–2.19)	1.27; (0.26)	0.60; (0.25–1.46)	1.59; (0.21)	0.53; (0.19–1.44)
rs740603	1.00; (0.32)	1.50; (0.68–3.27)	0.35; (0.55)	0.79; (0.36–1.72)	1.48; (0.22)	0.66; (0.33–1.30)	0.48; (0.49)	1.37; (0.56–3.39)	4.46; (0.03)	2.73; (1.06–7.03)

NB: significant P values are presented in bold.